| 标题 |
Lung-MAP S1800D: A phase II/III study of N-803 (ALT-803) plus pembrolizumab versus standard of care in participants with stage IV or recurrent non-small cell lung cancer (NSCLC) previously treated with anti-PD-1 or antiPD-L1 therapy
Lung-MAP S1800D：一项在既往接受过抗PD-1或抗PD-L1治疗的IV期或复发性非小细胞肺癌(NSCLC)参与者中进行的N-803（ALT-803）联合派姆单抗与标准治疗对比的II/III期研究
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 | JCO. 2024;42(16_suppl):2619–2619. |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
cdercder
Kao
22336
yjh123
ale
rico
嘉心糖
Copyright
寻雯静
arniu2008
Nole
sagitar
lx
christina
JIAGY
大力的冬萱
DRLIU
天晴
叶子666
pokexuejiao
皖公网安备34019202002308
